Post by
AjarnEvan on Mar 21, 2023 4:06pm
This is a prime junior pharma biotech play
The big boys must be salivating at the potential of this company. How long until they can't ignore the indisputable competive advantage any longer. If a buyout happens I'm all for it but it seems like Pharmala has the means to go at it independently. Buy and hold.